Serum antibody response to Chlamydia trachomatis TroA and HtrA in women with tubal factor infertility

被引:0
作者
T. Rantsi
P. Joki-Korpela
K. Hokynar
I. Kalliala
H. Öhman
H-M. Surcel
J. Paavonen
A. Tiitinen
M. Puolakkainen
机构
[1] University of Helsinki and Helsinki University Hospital,The Department of Obstetrics and Gynecology
[2] University of Helsinki and Helsinki University Hospital,Virology and Immunology
[3] Imperial College,Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Faculty of Medicine
[4] National Institute for Health and Welfare,Faculty of Medicine
[5] University of Oulu,undefined
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2018年 / 37卷
关键词
Persistent infection; TroA; HtrA; Serology; Tubal factor infertility;
D O I
暂无
中图分类号
学科分类号
摘要
Persistent genital chlamydial infection may lead to tubal factor infertility (TFI). Chlamydia trachomatis TroA and HtrA are proteins expressed during persistent chlamydial infection in vitro. We studied serum IgG antibody response against these proteins by EIA in women with TFI and in subfertile women without tubal pathology. Altogether, 22 of 258 subfertile women (8.5%) had TFI which was unilateral in 17 cases and bilateral in 5 cases. Overall, 55 (21.3%) of the 258 women had TroA and 39 (15.1%) had HtrA antibodies. Seropositivity to TroA and HtrA was more common among women with TFI than women with other causes for subfertility (45.5 vs. 19.1%, p = 0.004 for TroA; 36.4 vs. 13.1%, p = 0.004 for HtrA). Mean absorbance values and the prevalence of TroA and HtrA antibodies increased with increasing severity of TFI. On the basis of our results, TroA and HtrA serology has the potential to be further developed to a specific biomarker for C. trachomatis-related TFI.
引用
收藏
页码:1499 / 1502
页数:3
相关论文
共 74 条
[11]  
Peeling RW(2013)Antibody to Results Immunol 3 33-39
[12]  
Philip SS(2014) proteins, TroA and HtrA, as a biomarker for Hum Reprod 29 953-963
[13]  
Low N(undefined) infection undefined undefined undefined-undefined
[14]  
Fairley CK(undefined)Performance of the APTIMA Combo 2 assay for detection of undefined undefined undefined-undefined
[15]  
Geisler WM(undefined) and undefined undefined undefined-undefined
[16]  
Land JA(undefined) in female urine and endocervical swab specimens undefined undefined undefined-undefined
[17]  
Evers JL(undefined) seropositivity is associated both with stillbirth and preterm delivery undefined undefined undefined-undefined
[18]  
Goossens VJ(undefined)Proof of concept: a bioinformatic and serological screening method for identifying new peptide antigens for undefined undefined undefined-undefined
[19]  
Wyrick PB(undefined)-related sequelae in women undefined undefined undefined-undefined
[20]  
Miller JD(undefined)Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: a systematic review with meta-analysis undefined undefined undefined-undefined